MIRA Pharmaceuticals (MIRA) Earnings Analysis
MIRA Pharmaceuticals (MIRA) next reports earnings on 2026-09-02. It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.64.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MIRA next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
MIRA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.03 USD | n/a | n/a | n/a |
| 2026-03-31 | -0.15 USD | -0.04 USD | -275% | Miss |
| 2025-11-13 | -1.18 USD | -1.18 USD | 0% | Beat |
| 2025-08-14 | -0.09 USD | -0.11 USD | +18.2% | Beat |
| 2025-05-14 | -0.11 USD | -0.15 USD | +26.7% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
MIRA valuation and analyst view
| Trailing P/E | -0.64 |
|---|---|
| Trailing EPS | -0.23387 USD |
| Price / book | 4.16 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is MIRA Pharmaceuticals (MIRA)'s next earnings date?
MIRA Pharmaceuticals is next scheduled to report on 2026-09-02.
Did MIRA beat earnings last quarter?
Consensus estimate data was not available for MIRA's 2026-05-14 report.
What is MIRA's earnings track record?
Over the last 4 reported quarters with consensus data, MIRA beat estimates 3 times (75%).
What is MIRA's current P/E ratio and EPS?
MIRA trades at a trailing P/E of -0.64 on trailing EPS of -0.2338707104703542 USD.
What do analysts rate MIRA?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).